Finance

Lists
49Z:FRA
BICO Group AB
€2.00
+0.10%
(+0.0020) 1D
Sep 4, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 49Z...
Open
€2.00
High
€2.00
Low
€2.00
Mkt. cap
1.52B
Avg. vol.
1.30K
Volume
0.00
52-wk high
€2.29
52-wk low
€1.19
No. of employees
554
Open
€2.00
High
€2.00
Low
€2.00
Mkt. cap
1.52B
Avg. vol.
1.30K
Volume
0.00
52-wk high
€2.29
52-wk low
€1.19
No. of employees
554
Profile
Bico Group is a Swedish bioconvergence company that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting. Bico Group began by producing bio-inks and bioprinters for culturing different cell types to enable applications like patient-derived implants. Bico Group was the first company to provide a standardized bio-ink product for sale over the internet. The company has ongoing collaborations with organizations including AstraZeneca, MedImmune, MIT and Takara Bio, and its bioprinters are used for research at Harvard University, Merck, Novartis, the U.S. Army, Toyota, Johnson & Johnson and more. Wikipedia
About BICO Group AB
CEO-
Employees554
FoundedJan 27, 2016
Headquarters-
SectorHealth care
Websitebico.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
386.90M
451.30M
329.90M
336.10M
Cost of goods sold
174.20M
215.90M
151.30M
136.90M
Cost of revenue
174.20M
215.90M
151.30M
136.90M
Research and development expenses
50.10M
48.80M
49.30M
56.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
204.10M
204.30M
224.80M
179.70M
Operating expense
259.60M
249.50M
269.80M
229.40M
Total operating expenses
433.80M
465.40M
421.10M
366.30M
Operating income
-46.90M
-14.10M
-91.20M
-30.20M
Other non operating income
-
-8.40M
-
-100.00K
EBT including unusual items
-1.11B
-57.00M
-127.50M
-34.90M
EBT excluding unusual items
-73.30M
-73.30M
-105.30M
-23.60M
Income tax expense
-2.20M
2.20M
3.80M
2.30M
Effective tax rate
0.20%
-3.86%
-2.98%
-6.59%
Other operating expenses
5.40M
-3.60M
-4.30M
-7.20M
Net income
-612.70M
-55.00M
-131.30M
-37.20M
Net profit margin
-158.36%
-12.19%
-39.80%
-11.07%
Earnings per share
-
-
-
-
Interest and investment income
2.70M
212.00M
9.10M
20.30M
Interest expense
-29.10M
-11.90M
-23.20M
-13.60M
Net interest expenses
-26.40M
200.10M
-14.10M
6.70M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.04B
48.40M
-20.10M
27.00M
Gain or loss from assets sale
-
-480.30M
-
-
AI content may include mistakes. Learn more
Google apps